IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

OncoTargets and Therapy- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

4.19

h-Index

 66

Rank

 5618

SJR

 0.811

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title OncoTargets and Therapy
Abbreviation OncoTargets Ther.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q2); Pharmacology (medical) (Q2)
h-index 66
Overall Rank/Ranking 5618
SCImago Journal Rank (SJR) 0.811
Impact Score 4.19
Publisher Dove Medical Press Ltd.
Country New Zealand
ISSN 11786930




About OncoTargets and Therapy


OncoTargets and Therapy is a journal covering the technologies/fields/categories related to Oncology (Q2); Pharmacology (medical) (Q2). It is published by Dove Medical Press Ltd.. The overall rank of OncoTargets and Therapy is 5618. According to SCImago Journal Rank (SJR), this journal is ranked 0.811. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 66. The best quartile for this journal is Q2.

The ISSN of OncoTargets and Therapy journal is 11786930. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. OncoTargets and Therapy is cited by a total of 12501 articles during the last 3 years (Preceding 2021).


OncoTargets and Therapy Impact Score 2021-2022


The impact score (IS) 2021 of OncoTargets and Therapy is 4.19, which is computed in 2022 as per its definition. OncoTargets and Therapy IS is increased by a factor of 0.34 and approximate percentage change is 8.83% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

OncoTargets and Therapy Impact Score 2022 Prediction


IS 2021 of OncoTargets and Therapy is 4.19. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of OncoTargets and Therapy. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 4.19
2020 3.85
2019 3.26
2018 3.14
2017 2.81
2016 2.85
2015 3.51
2014 3.26

OncoTargets and Therapy h-index


  Table Setting

OncoTargets and Therapy has an h-index of 66. It means 66 articles of this journal have more than 66 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




OncoTargets and Therapy ISSN


The ISSN of OncoTargets and Therapy is 11786930. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

OncoTargets and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of OncoTargets and Therapy is 5618. According to SCImago Journal Rank (SJR), this journal is ranked 0.811. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


OncoTargets and Therapy Publisher


Table Setting

OncoTargets and Therapy is published by Dove Medical Press Ltd.. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2009-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of OncoTargets and Therapy is OncoTargets Ther.. This abbreviation ('OncoTargets Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in OncoTargets and Therapy


If your research field is/are related to Oncology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Revue des Sciences Philosophiques et Theologiques journal 26346 Librairie Philosophique J. Vrin 7 0.07
Biomaterials Science journal 2884 Royal Society of Chemistry 75 7.02
Clinical Plasma Medicine journal 9062 Elsevier GmbH 26 3.08
Epilepsy Currents journal 10580 American Epilepsy Society 25 1.19
Journal of Military Ethics journal 16507 Routledge 22 0.27
Israel Journal of Ecology and Evolution journal 15260 Brill Academic Publishers 34 1.13
Journal of Molecular Structure journal 10394 Elsevier 110 3.57
Zeitschrift fur Romanische Philologie journal 21950 Walter de Gruyter GmbH 8 0.10
Fotocinema journal 22473 Universidad de Malaga, Departamento de Historia del Arte 1 0.20
Transforming Government: People, Process and Policy journal 7409 Emerald Group Publishing Ltd. 39 3.15

Check complete list




Year wise Impact Score (IS) of OncoTargets and Therapy

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 4.19
2020 3.85
2019 3.26
2018 3.14
2017 2.81
2016 2.85
2015 3.51
2014 3.26



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All